New Clinically Significant QTc Prolongation Percentage of new events No. of remaining patients without QTc prolongation McNemar’s p for comparison with conventional monitoring
Conventional 3 3% 87
First Day 16 18% 71 0.0003
Second Day 8 11% 63 0.025
Third Day 7 11% 56 0.045
Fourth Day 3 5% 53 NS
Fifth Day 4 8% 49 NS
Sixth Day 1 2% 48 NS
Seventh Day 0 0% 48 NS
7 Days Holter 39 43% 51 <0.001